Pedro Rocha - Concepedia

Author

Pedro Rocha

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

P. Rocha, PEDRO PAULO PIRES DE DEUS ROCHA, Pedro Da Rocha, Pedro Rocha, Pedro da Rocha, Rocha, Pedro

131

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Hospital Del Mar Hospital del Mar Research Institute Universitat de Barcelona Centro de Investigación Biomédica en Red de Cáncer

About

Pedro Rocha is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	470
2	Health Sciences	2	2	86
3	Engineering	1	1	87
4	Allergy	1	1	35
5	Cell Biology	1	1	31

Pedro Rocha

Publications

894

Citations

H-Index

Page 1

	Year	Citations
Prevalence of atrial fibrillation in the Portuguese population aged 40 and over: the FAMA study. D Bonhorst, Miguel Mendes, Pedro Adragão, PubMed	2010	110
Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes Simon Heeke, Carl M. Gay, Marcos R. Estecio, Cancer Cell Cfdna ClassifierEngineeringEpigenetic ChangeDna MethylationPathology	2024	87
Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer Max Hardy-Werbin, Pedro Rocha, Oriol Arpí, OncoImmunology	2019	85
Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples David Casadevall, Sergi Clavé, Álvaro Taus, Clinical Lung Cancer Cancer ImmunosurveillanceMalignant DiseaseMedicineImmunologyTumor Immunity	2017	84
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy Giannis Mountzios, Longhua Sun, Byoung Chul Cho, New England Journal of Medicine	2025	83
Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy Marta Casarrubios, Alberto Cruz‐Bermúdez, Ernest Nadal, Clinical Cancer Research	2021	61
Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung Adenocarcinoma Álvaro Taus, Laura Camacho, Pedro Rocha, Clinical Lung Cancer Egfr Mutation LoadOncologyTumor HeterogeneityMedicineEgfr-mutant Lung Adenocarcinoma	2018	49
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study Amin H. Nassar, So Yeon Kim, Jacqueline V. Aredo, Journal of Thoracic Oncology Health SciencesMedicineConcurrent ChemoradiationCancer TreatmentOncology	2024	37
Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non–small-cell Lung Cancer: Implications of FISH-positive Patterns Sergi Clavé, Natàlia Rodón, Lara Pijuán, Clinical Lung Cancer Non–small-cell Lung CancerRos1 Rearrangement DetectionOncologyMedicinePathology	2019	36
CD103+CD8+ Lymphocytes Characterize the Immune Infiltration in a Case With Pseudoprogression in Squamous NSCLC Pedro Rocha, Max Hardy-Werbin, Dolores Naranjo, Journal of Thoracic Oncology InflammationCd103+cd8+ Lymphocytes CharacterizeAllergySquamous NsclcGranulocyte	2018	35

Page 1